Divided Federal Circuit Affirms: Schizophrenia Treatment Patent Infringed
WASHINGTON, D.C. — In an April 13 holding, the Federal Circuit U.S. Court of Appeals upheld a Delaware federal judge’s determination that a patented method of treating schizophrenia patients with iloperidone,...To view the full article, register now.
Already a subscriber? Click here to view full article